De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China by Jie Luo, Xin Du, Jin Lou, Jianwei Wu, Liping Ma, Jixian Huang, Liangtuo Wang, Chuanqing Tu, Zelin Liu, Liya Chen, Yaxian Tan, Dongmei Luo, Hanyin Liang, Changxin Yin, Rui Cao, Xuan Zhou, Qifa Liu, Xiaoli Liu, Na Xu

Get full text